How Medical Technology is Aiding the Global Fight Against Covid-19
Healthcare organizations worldwide have been forced to adapt and evolve as the coronavirus pandemic has raged across the world. Existing...
Month: March 2021
Abattis and Management Overcome Legal and Regulatory Allegations
After Over Two Years of Legal and Regulatory Battles, Abattis & its Management Receive Vindication VANCOUVER, British Columbia, March 19,...
Celsion Corporation Reports 2020 Financial Results and Provides Business Update
Entered 2021 with a Focus on Cancer Immunotherapy and Next-Generation Infectious Vaccines and a Strong Balance Sheet Conference Call Begins at...
EarthRenew to Webcast Live at Life Sciences Investor Forum on March 25, 2021
EarthRenew invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum.comTORONTO, March...
Virtual Conference for Life Sciences Companies Broadcast Live March 25th, 2021
Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.comNEW YORK , March 19, 2021 (GLOBE NEWSWIRE) --...
US FDA approves Ponvory (ponesimod) to treat adults with relapsing forms of multiple sclerosis
Allschwil, Switzerland – March 19, 2021 Idorsia Ltd (SIX: IDIA) was informed by the Janssen Pharmaceutical Companies of Johnson &...
MagicMed Industries to Present at the Q1 Virtual Investor Summit
CALGARY, Alberta, March 19, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- MagicMed Industries Inc. ("MagicMed" or the "Company"), a biotechnology...
X4 Pharmaceuticals Announces $55.0 Million At-the-Market Private Placement Financing
BOSTON, March 19, 2021 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of...
Wave Life Sciences to Present at the Third Annual Stifel CNS Day
CAMBRIDGE, Mass., March 19, 2021 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed...
SparingVision Announces Upcoming Presentations at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting
SparingVision Announces Upcoming Presentations at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting Paris, March 19,...
Longeveron Inc. to Present at the Q1 Virtual Investor Summit on March 24
MIAMI, March 19, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage...
President & CEO of Nova Leap Health Corp. to Present at the Q1 Virtual Investor Summit
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, March 19, 2021...
Revive Therapeutics Announces Successful Research Results for Psilocybin to Treat Traumatic Brain Injury and Filing of International Patent Application
TORONTO, March 19, 2021 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty...
BioCryst Appoints Helen Thackray, M.D., as Chief Research and Development Officer
RESEARCH TRIANGLE PARK, N.C., March 19, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company has...
Tonix Pharmaceuticals Announces Issuance of U.S. Patent for Compositions and Uses of Tianeptine Oxalate Salt, the Active Ingredient of TNX-601 CR
CHATHAM, N.J., March 19, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage...
Availability of the Q1 2021 Memorandum for modelling purposes
Availability of the Q1 2021 Memorandum for modelling purposes Paris, France – March 19, 2020 - Sanofi announced today that its...
The Ensign Group, Inc. Declares Quarterly Dividend of $0.0525 Per Share
SAN JUAN CAPISTRANO, Calif., March 19, 2021 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of...
SparingVision Announces Upcoming Presentations at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting
SparingVision Announces Upcoming Presentations at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting Paris, March 19,...
Angion Announces Partial Waiver of Certain Lock-up Restrictions
UNIONDALE, N.Y., March 19, 2021 (GLOBE NEWSWIRE) -- Angion Biomedica Corp. (NASDAQ:ANGN), a late-stage biopharmaceutical company focused on the discovery,...
Connect Biopharma Holdings Limited announces pricing of Initial Public Offering
SAN DIEGO and TAICANG, China, March 18, 2021 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (the “Company”), a global clinical-stage...